FIELD: chemistry.
SUBSTANCE: present invention relates to a compound having the structural formula I , or its pharmaceutically acceptable salt, ester or amide, where A has the structure , where each bond in A, represented by a dotted and a solid line, represents a carbon-carbon single bond; each of a, b and c is a carbon atom; each of e, f, g and h is a carbon atom; X is nitrogen; X' is C; L is absent; each n equals 1; Y is nitrogen; W is nitrogen; R1 is hydrogen; each of R2, R3 and R4 is a hydrogen atom; each of R6, R8 and R9 is a hydrogen atom; R5 is selected from a group consisting of halogen, C1-6alkyl, optionally substituted with a hydroxy group, and C1-6alkoxy; R7 is selected from a group consisting of halogen, C1-6alkyl and perhalogenalkyl; Z is selected from a group consisting of NR11, oxygen and CH2; R11 is hydrogen; and each bond in formula I, represented by a dotted and a solid line, is a carbon-carbon double bond. The invention also relates to a method for synthesis of a formula V compound, a pharmaceutical composition based on a formula I compound, methods of treating psychoneurological disorders, a pharmaceutical composition containing a formula I compound and a psychoneurological agent.
EFFECT: obtaining novel compounds useful for modulating muscarine receptor activity.
37 cl, 1 tbl, 141 ex
Title | Year | Author | Number |
---|---|---|---|
NON-STEROIDAL MODULATORS OF PROGESTERONE RECEPTOR | 2003 |
|
RU2309155C2 |
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
DERIVATIVES OF 5H-DIBENZO[b, e][1, 4]DIAZEPINE AND ITS APPLICATION | 2010 |
|
RU2441867C2 |
BICYCLIC PYRIDINES AND ANALOGUES AS SIRTUIN MODULATORS | 2010 |
|
RU2550821C2 |
0 |
|
SU475777A3 | |
AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | 2004 |
|
RU2423363C2 |
1,2-DI(CYCLO)SUBSTITUTED BENZOLE DERIVATIVES | 2004 |
|
RU2340602C2 |
INHIBITOR CONTAINING A TRICYCLIC DERIVATIVE, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800543C2 |
TRICYCLIC DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND METHOD OF INHIBITION OF VASOPRESSINE | 1994 |
|
RU2149160C1 |
Authors
Dates
2010-07-10—Published
2004-12-21—Filed